Human Pathology
Volume 37, Issue 3 , Pages 312-321 , March 2006

Calretinin expression in tumors of adipose tissue

  • Justin M.M. Cates, MD, PhD

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Bryan N. Coffing, MD

      Affiliations

    • Department of Pathology, University of Michigan Health System, Ann Arbor, MI 48109, USA
    • ,
  • Brent T. Harris, MD, PhD

      Affiliations

    • Department of Pathology, Dartmouth Hitchcock Medical Center and Dartmouth Medical School, Lebanon, NH 03756, USA
    • ,
  • Candice C. Black, DO

      Affiliations

    • Department of Pathology, Dartmouth Hitchcock Medical Center and Dartmouth Medical School, Lebanon, NH 03756, USA

Received 1 September 2005 ,Revised 8 November 2005 ,Accepted 9 November 2005.

References 

  1. Rogers J, Khan M, Ellis J. Calretinin and other CaBPs in the nervous system. Adv Exp Med Biol. 1990;269:195–203
  2. Heizmann CW, Hunziker W. Intracellular calcium-binding proteins: more sites than insights. Trends Biochem Sci. 1991;16:98–103
  3. Billing-Marczak K, Kuznicki J. Calretinin—sensor or buffer—function still unclear. Pol J Pharmacol. 1999;51:173–178
  4. Tos AP, Doglioni C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol. 1998;5:61–66
  5. Doglioni C, Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20:1037–1046
  6. Fine SW, McClain SA, Li M. Immunohistochemical staining for calretinin is useful for differentiating schwannomas from neurofibromas. Am J Clin Pathol. 2004;122:552–559
  7. Gotzos V, Wintergerst ES, Musy JP, Spichtin HP, Genton CY. Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. Am J Surg Pathol. 1999;23:701–711
  8. Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2001;20:346–352
  9. Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract. 1996;192:137–147
  10. Lugli A, Forster Y, Haas P, et al. Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol. 2003;34:994–1000
  11. Val-Bernal JF, Gonzalez-Vela MC, Cuevas J. Primary purely intradermal pleomorphic liposarcoma. J Cutan Pathol. 2003;30:516–520
  12. Attanoos RL, Dojcinov SD, Webb R, Gibbs AR. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology. 2000;37:224–231
  13. Lucas DR, Pass HI, Madan SK, et al. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology. 2003;42:270–279
  14. Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol. 2001;25:610–617
  15. Cappello F, Barnes L. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis. Pathology. 2001;33:142–148
  16. Mikami Y, Nakajima M, Hashimoto H, Kuwabara K, Sasao Y, Manabe T. Primary poorly differentiated monophasic synovial sarcoma of the lung. A case report with immunohistochemical and genetic studies. Pathol Res Pract. 2003;199:827–833
  17. Shah VI, Freites ON, Maxwell P, McCluggage WG. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol. 2003;56:221–224
  18. Zhang PJ, Goldblum JR, Pawel BR, Fisher C, Pasha TL, Barr FG. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol. 2003;16:229–235
  19. McCluggage WG, Maxwell P. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology. 2001;38:403–408
  20. Laskin WB, Miettinen M. Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis. Arch Pathol Lab Med. 2003;127:1161–1168
  21. Acebo E, Val-Bernal JF, Gomez-Roman JJ. Thrombomodulin, calretinin and c-kit (CD117) expression in cardiac myxoma. Histol Histopathol. 2001;16:1031–1036
  22. Terracciano LM, Mhawech P, Suess K, et al. Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol. 2000;114:754–759
  23. Morgan MB, Smoller BR. Solitary fibrous tumors are immunophenotypically distinct from mesothelioma(s). J Cutan Pathol. 2000;27:451–454
  24. Yang F, Tran TA, Carlson JA, Hsi ED, Ross CW, Arber DA. Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms. Am J Surg Pathol. 2000;24:703–709
  25. Mangini J, Silverman JF, Dabbs DJ, Tung MY, Silverman AR. Diagnostic value of calretinin in mast cell lesions of the skin. Int J Surg Pathol. 2000;8:119–122
  26. Miettinen M, Sarlomo-Rikala M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol. 2003;27:150–158
  27. Gupta D, Deavers MT, Silva EG, Malpica A. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases. Am J Surg Pathol. 2004;28:771–780
  28. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol. 2002;26:1477–1483
  29. Cathro HP, Stoler MH. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Hum Pathol. 2005;36:195–201
  30. Mayall FG, Gibbs AR. The histology and immunohistochemistry of small cell mesothelioma. Histopathology. 1992;20:47–51
  31. Shimazaki H, Aida S, Iizuka Y, Yoshizu H, Tamai S. Vacuolated cell mesothelioma of the pericardium resembling liposarcoma: a case report. Hum Pathol. 2000;31:767–770
  32. In:  Fletcher CDM,  Unni KK,  Mertens F editor. World Health Organization Classification of Tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002;p. 10–11
  33. Foster MR, Johnson JE, Olson SJ, Allred DC. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas. Arch Pathol Lab Med. 2001;125:1316–1320
  34. Winsky L, Kuznicki J. Antibody recognition of calcium-binding proteins depends on their calcium-binding status. J Neurochem. 1996;66:764–771
  35. Zimmermann L, Schwaller B. Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells. Cell Calcium. 2002;31:13–25
  36. Klug M, Blum JK, Ye Q, Berchtold MW. Intracellular Ca2+ and Ca(2+)-binding proteins in chemically transformed rat fibroblasts. Exp Cell Res. 1994;213:313–318
  37. Hashimoto H, Daimaru Y, Enjoji M. S-100 protein distribution in liposarcoma. An immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma. Virchows Arch A Pathol Anat Histopathol. 1984;405:1–10
  38. Gibas Z, Miettinen M, Limon J, et al. Cytogenetic and immunohistochemical profile of myxoid liposarcoma. Am J Clin Pathol. 1995;103:20–26
  39. Hasegawa T, Seki K, Hasegawa F, et al. Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histological grades—a clinicopathologic study of 32 cases. Hum Pathol. 2000;31:717–727
  40. Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CD. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257–1267

☆ The Research Pathology Division at Dartmouth Hitchcock Medical Center, Lebanon, NH, provided the financial and technical support for this study.

PII: S0046-8177(05)00636-2

doi: 10.1016/j.humpath.2005.11.006

Human Pathology
Volume 37, Issue 3 , Pages 312-321 , March 2006

Article Tools

* Image Usage & Resolution